GSEA data indicated that pathways such as DNA replication, cell cycle, oxidative phosphorylation, and homologous recombination were significantly enriched when SPARCL1 was downregulated, revealing potential molecular mechanisms by which SPARCL1 participates in BC. This evidence concerns the gene SPARCL1 and breast cancer.